HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genome-wide association study of iron traits and relation to diabetes in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL): potential genomic intersection of iron and glucose regulation?

Abstract
Genetic variants contribute to normal variation of iron-related traits and may also cause clinical syndromes of iron deficiency or excess. Iron overload and deficiency can adversely affect human health. For example, elevated iron storage is associated with increased diabetes risk, although mechanisms are still being investigated. We conducted the first genome-wide association study of serum iron, total iron binding capacity (TIBC), transferrin saturation, and ferritin in a Hispanic/Latino cohort, the Hispanic Community Health Study/Study of Latinos (>12 000 participants) and also assessed the generalization of previously known loci to this population. We then evaluated whether iron-associated variants were associated with diabetes and glycemic traits. We found evidence for a novel association between TIBC and a variant near the gene for protein phosphatase 1, regulatory subunit 3B (PPP1R3B; rs4841132, β = -0.116, P = 7.44 × 10-8). The effect strengthened when iron deficient individuals were excluded (β = -0.121, P = 4.78 × 10-9). Ten of sixteen variants previously associated with iron traits generalized to HCHS/SOL, including variants at the transferrin (TF), hemochromatosis (HFE), fatty acid desaturase 2 (FADS2)/myelin regulatory factor (MYRF), transmembrane protease, serine 6 (TMPRSS6), transferrin receptor (TFR2), N-acetyltransferase 2 (arylamine N-acetyltransferase) (NAT2), ABO blood group (ABO), and GRB2 associated binding protein 3 (GAB3) loci. In examining iron variant associations with glucose homeostasis, an iron-raising variant of TMPRSS6 was associated with lower HbA1c levels (P = 8.66 × 10-10). This association was attenuated upon adjustment for iron measures. In contrast, the iron-raising allele of PPP1R3B was associated with higher levels of fasting glucose (P = 7.70 × 10-7) and fasting insulin (P = 4.79 × 10-6), but these associations were not attenuated upon adjustment for TIBC-so iron is not likely a mediator. These results provide new genetic information on iron traits and their connection with glucose homeostasis.
AuthorsLaura M Raffield, Tin Louie, Tamar Sofer, Deepti Jain, Eli Ipp, Kent D Taylor, George J Papanicolaou, Larissa Avilés-Santa, Leslie A Lange, Cathy C Laurie, Matthew P Conomos, Timothy A Thornton, Yii-Der Ida Chen, Qibin Qi, Scott Cotler, Bharat Thyagarajan, Neil Schneiderman, Jerome I Rotter, Alex P Reiner, Henry J Lin
JournalHuman molecular genetics (Hum Mol Genet) Vol. 26 Issue 10 Pg. 1966-1978 (05 15 2017) ISSN: 1460-2083 [Electronic] England
PMID28334935 (Publication Type: Journal Article)
Copyright© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].
Chemical References
  • Antigens, CD
  • Blood Glucose
  • CD71 antigen
  • Insulin
  • Membrane Proteins
  • Receptors, Transferrin
  • Transferrin
  • Ferritins
  • Iron
  • Serine Endopeptidases
  • TMPRSS6 protein, human
  • Glucose
Topics
  • Adult
  • Anemia, Iron-Deficiency (blood)
  • Antigens, CD
  • Blood Glucose (metabolism)
  • Diabetes Mellitus (genetics, metabolism)
  • Fasting
  • Female
  • Ferritins (analysis, blood, metabolism)
  • Genetic Association Studies (methods)
  • Genetic Variation (genetics)
  • Genome-Wide Association Study
  • Genomics
  • Glucose (genetics, metabolism)
  • Hemochromatosis (genetics)
  • Hispanic or Latino (genetics)
  • Hospitals, Community (methods)
  • Humans
  • Insulin (metabolism)
  • Iron (blood, metabolism)
  • Male
  • Membrane Proteins (genetics, metabolism)
  • Middle Aged
  • Phenotype
  • Polymorphism, Single Nucleotide (genetics)
  • Receptors, Transferrin (genetics)
  • Risk Factors
  • Serine Endopeptidases (genetics, metabolism)
  • Transferrin (analysis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: